Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.97%
#3 BankrCoin BankrCoin +19.53%
#4 Ankr Network Ankr Network +17.24%
#5 Hive Hive +16.87%
#6 StonkBroker StonkBroker +16.12%
#7 ICON ICON +13.08%
#8 Status Status +12.07%
#9 Prom Prom +9.87%
#10 Provenance Blockchain Provenance Blockchain +9.17%
Coin of the day
Palladium Network Palladium Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Peringkat dalam Saham #18285
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Harga Saham
$5.59
Terakhir disinkronkan: 2026-09-02
Kapitalisasi Pasar
$205.21M
Perubahan (1 hari)
6.27%
Perubahan (1 tahun)
86.33%
Negara
US
Perdagangan Armata Pharmaceuticals, Inc. (ARMP)

Kategori

Healthcare
Laba untuk Armata Pharmaceuticals, Inc. (ARMP)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Armata Pharmaceuticals, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Armata Pharmaceuticals, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH